CAMBRIDGE, Mass., May 25, 2021 /PRNewswire/ -- Blueprint
Medicines Corporation (NASDAQ: BPMC) today announced its
participation in the following upcoming investor conferences.
- Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:30 p.m. ET.
- Goldman Sachs 42nd Annual Global Healthcare
Conference on Thursday, June 10,
2021 at 8:50 a.m. ET.
- JMP Securities Life Sciences Conference on Wednesday, June 16, 2021 at 1:00 p.m. ET.
A live webcast of each presentation will be available by
visiting the Investors & Media section of Blueprint
Medicines' website at http://ir.blueprintmedicines.com. A
replay of the webcasts will be archived on Blueprint
Medicines' website for 30 days following each
presentation.
About Blueprint Medicines
Blueprint Medicines is a global precision therapy company that
invents life-changing medicines for people with cancer and
hematologic disorders. Applying an approach that is both precise
and agile, we create therapies that selectively target genetic
drivers, with the goal of staying one step ahead across stages of
disease. Since 2011, we have leveraged our research platform,
including expertise in molecular targeting and world-class drug
design capabilities, to rapidly and reproducibly translate science
into a broad pipeline of precision therapies. Today, we are
delivering our approved medicines to patients in the United States and Europe, and we are globally advancing multiple
programs for genomically defined cancers, systemic mastocytosis,
and cancer immunotherapy. For more information,
visit www.BlueprintMedicines.com and follow us
on Twitter (@BlueprintMeds) and LinkedIn.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-upcoming-investor-conferences-301298404.html
SOURCE Blueprint Medicines Corporation